Global Health Investment Corporation
Impact investorNew York · Seed–Series B · 2 people tracked
Also known as GHIC ADVISORS, LLC
Investment thesis
GHIC invests to catalyze technologies that improve human health worldwide, focusing on strengthening global health security and addressing urgent challenges such as infectious disease and maternal and child health. Its namesake $108M social impact fund (GHIF) backed twelve companies developing clinical diagnostics, devices, vaccines, and therapeutics targeting infectious diseases that disproportionately affect low- and middle-income countries, including HIV/AIDS, malaria, tuberculosis, and cholera. In partnership with BARDA at the U.S. Department of Health and Human Services, GHIC uses venture investments to support technologies that respond to or prevent public health emergencies such as pandemics and other global health security threats.
Source: firm website, verified Aug 25, 2026.
Team · 2 people
from the firm's website & public directories
What they invest in
from 2 of 4 portfolio companiesBiotech ×2Advanced Manufacturing ×1Healthtech ×1
HQs:United States×2
Investments · 4 tracked
founders shown can be your intro path
Antheia uses a yeast-based biosynthesis and fermentation platform to manufacture Key Starting Materials (KSMs) and Active Pharmaceutical Ingredients (APIs) for essential medicines, offering an alternative to fragile agricultural sourcing.
Advanced ManufacturingBiotechHealthtechMenlo Park, US
Christina D. Smolke(Executive Officer, Director)Christina Smolke(Co-Founder & CEO)inKristy Hawkins(Co-Founder & CSO)inEric d'Esparbes(Chief Financial Officer)inZack McGahey(Chief Operating Officer)inHeidi Pucel(Chief People Officer)in
Co-investorsAmerica's Frontier FundCivilization Ventures Management, LlcLam CapitalSherpalo Ventures
Co-investorsAdBio partnersIn-Q-Tel
BiotechCambridge, US
Livio Valenti(Executive Officer)Kathryn Kosuda(Executive Officer, Director)Michael Schrader(Executive Officer, Director)Matthew Dirckx(Executive Officer)Lynda Tussey(Executive Officer)John Spiridigliozzi(Executive Officer)
Co-investorsMission BiocapitalRA Capital
Portfolio news
latest coverage across their companiesVaxess Technologies, Inc. · finsmes.com · Mar 26, 2026
Antheia, Inc. · fiercepharma.com · Jan 28, 2026
Frequently asked questions
- What stage does Global Health Investment Corporation invest at?
- Global Health Investment Corporation invests at the Seed, Series A, Series B stages.
- What sectors does Global Health Investment Corporation focus on?
- Global Health Investment Corporation focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
- Where is Global Health Investment Corporation located?
- Global Health Investment Corporation is headquartered in New York, US.
Co-investors · 3
Entrepreneur First (EF) is a talent investor that helps individuals build and launch startups, providing support such as US visa guidance, office space, fundraising preparation, and investor introductions culminating in a San Francisco Demo Day.
Adjuvant Capital is a venture capital firm that finances life science technologies addressing high-burden public health challenges, aiming to deliver both social and financial returns.
Global Health Investment Corporation is a nonprofit organization that invests in life sciences and healthcare technology companies to develop and commercialize products addressing global health challenges, particularly infectious diseases and maternal and child health in low- and middle-income countries.
Firms observed investing alongside Global Health Investment Corporation, from public investor directories. Shared companies are the overlap with Global Health Investment Corporation's recorded portfolio.
Similar investors
Lerer Hippeau is an early-stage venture capital firm that backs founders across sectors, emphasizing investing in companies before they gain wider recognition.
Cancer Fund is an early-stage oncology venture capital and venture-giving organization that funds diagnostics, therapeutics, and other cancer-targeting innovations, offering both charitable donation and accredited-investor pathways.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
MDI Ventures is the corporate venture capital arm of Telkom Indonesia, investing in and building synergies between technology startups and Indonesian enterprises. It manages a multi-fund platform (including Centauri Fund, Arise, and sector-specific funds) with a portfolio of 80+ companies.
Asabys Partners is a healthcare and life sciences venture capital firm that invests in innovative science and medical technologies to improve patients' lives.